Bougnoux P, Germain E, Chajès V, Hubert B, Lhuillery C, Le Floch O, Body G, Calais G
Laboratoire de Biologie des Tumeurs et Clinique d'Oncologie-Radiothérapie, Hôpital Bretonneau, Tours, France.
Br J Cancer. 1999 Apr;79(11-12):1765-9. doi: 10.1038/sj.bjc.6690281.
Experimental studies indicated that long-chain polyunsaturated fatty acids may increase sensitivity of mammary tumours to several cytotoxic drugs. To evaluate this hypothesis in breast cancer, we have prospectively studied the association between levels of fatty acids stored in breast adipose tissue and the response of the tumour to chemotherapy in 56 patients with an initially localized breast carcinoma. Adipose breast tissue was obtained at the time of biopsy, and individual fatty acids were measured as a percentage of total fatty acids using capillary gas chromatography. Patients then received primary chemotherapy, combining mitoxantrone, vindesine, cyclophosphamide and 5-fluorouracil every 4 weeks. Tumour size was reassessed after three cycles of chemotherapy. Tumour response was evaluated according to World Health Organization criteria. Complete or partial response to chemotherapy was achieved in 26 patients (47%). Level of n-3 polyunsaturated fatty acids in adipose tissue was higher in the group of patients with complete or partial response to chemotherapy than in patients with no response or with tumour progression (P < 0.004). Among n-3 polyunsaturated, only docosahexaenoic acid (22:6n-3) was significantly associated with tumour response (P < 0.005). In a logistic regression analysis taking into account age, body mass index and tumour size, 22:6 n-3 level proved to be an independent predictor for chemosensitivity (P = 0.03). These results suggest that, in breast cancer, 22:6 n-3 may increase the response of the tumour to the cytotoxic agents used.
实验研究表明,长链多不饱和脂肪酸可能会增加乳腺肿瘤对几种细胞毒性药物的敏感性。为了在乳腺癌中评估这一假说,我们前瞻性地研究了56例初发局部乳腺癌患者乳腺脂肪组织中储存的脂肪酸水平与肿瘤对化疗反应之间的关联。在活检时获取乳腺脂肪组织,使用毛细管气相色谱法将各个脂肪酸作为总脂肪酸的百分比进行测量。患者随后接受一线化疗,每4周联合使用米托蒽醌、长春地辛、环磷酰胺和5-氟尿嘧啶。化疗三个周期后重新评估肿瘤大小。根据世界卫生组织标准评估肿瘤反应。26例患者(47%)对化疗达到完全或部分缓解。化疗完全或部分缓解患者组脂肪组织中n-3多不饱和脂肪酸水平高于无反应或肿瘤进展患者组(P<0.004)。在n-3多不饱和脂肪酸中,只有二十二碳六烯酸(22:6n-3)与肿瘤反应显著相关(P<0.005)。在一项考虑年龄、体重指数和肿瘤大小的逻辑回归分析中,22:6 n-3水平被证明是化疗敏感性的独立预测因素(P=0.03)。这些结果表明,在乳腺癌中,22:6 n-3可能会增加肿瘤对所用细胞毒性药物的反应。